journal article text

Supplementary Data from Development of Immunohistochemistry Assays to Assess GALNT14 and FUT3/6 in Clinical Trials of Dulanermin and Drozitumab

Authors
Publication date
1 March 2010
Publisher
Doi

    Abstract

    Supplementary Data from Development of Immunohistochemistry Assays to Assess GALNT14 and FUT3/6 in Clinical Trials of Dulanermin and Drozituma

      Similar works

      Full text

      thumbnail-image

      Available Versions

      The Francis Crick Institute

      redirect
      oaioai:figshare.com:article/22441...
      Last time updated on 02/04/2023